Quality Attribute Identification
Quality Attribute Identification is a systematic process within pharmaceutical development that determines the critical quality attributes of a drug product by establishing measurable physical, chemical, biological, or microbiological properties that must be controlled to ensure the desired safety, efficacy, and quality of the final medicinal product.
55
Publications
2.1K
Citations
228
Authors
84
Institutions
Publications per year
2017–2026
18
Parents
55
228
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 228
84

University of Life Sciences in Poznań
Poznań, Poland
3 h-index
17 publications
398 citations
Wageningen University & Research
Wageningen, The Netherlands
3 h-index
9 publications
265 citations
Chung Hua University
Hsinchu, Taiwan
2 h-index
3 publications
202 citations
Amgen (United States)
Thousand Oaks, United States
2 h-index
2 publications
90 citations

Poznań University of Technology
Poznan, Poland
2 h-index
2 publications
32 citations
Colorado State University
Fort Collins, United States
2 h-index
12 publications
231 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
8 publications
188 citations
Eli Lilly (United States)
Indianapolis, United States
2 h-index
4 publications
140 citations
1–8 of 84
JFS · 3 publications · 91 citations
3
h-index
2 publications · 34 citations
2
h-index
AAPSJ · 2 publications · 44 citations
2
h-index
2 publications · 167 citations
2
h-index
JBS · 2 publications · 71 citations
2
h-index
1–5